Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on COVID-19 course and outcomes in patients receiving different DMTs was conducted a...
Main Authors: | Verónica Cabreira, Pedro Abreu, Ricardo Soares-dos-Reis, Joana Guimarães, Maria José Sá |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/7/773 |
Similar Items
-
Vaccination in Individuals with Multiple Sclerosis – Part II
by: Aslı Tuncer, et al.
Published: (2023-06-01) -
Vaccination in Individuals with Multiple Sclerosis – Part I
by: Bilge Piri Çınar, et al.
Published: (2023-04-01) -
Multiple sclerosis : recovery of function and neurorehabilitation /
by: Kesselring, Jurg, et al.
Published: (c201) -
Multiple sclerosis /
by: 546326 Dobson, Ruth, et al.
Published: (2013) -
Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)